AbbVie Inc

NYSE:ABBVUnited States

AbbVie Inc. is a diversified research-based biopharmaceutical company engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers, and others. It offers NX-13 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). It also offers CEL383 for the treatment of inflammatory bowel disease.

Contact Information

Headquarters

1 N Waukegan RdNORTH CHICAGO, IL, United States 60064

Phone

847-932-7900

Fax

302-655-5049

Executives

Executive Chairman of the Board

Richard Gonzalez

Chief Executive Officer, Director

Robert Michael

Chief Financial Officer, Executive Vice President

Scott Reents

Chief Human Resource Officer, Executive Vice President

Timothy Richmond

Executive Vice President - Research & Development, Chief Scientific Officer

Roopal Thakkar